Evonik Industries AG (EVK)-Financial and Strategic SWOT Analysis Review
July 2017
55
About the Report
About the Report
Evonik Industries AG (EVK)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Business description-A detailed description of the company operations and business divisions.
Corporate strategy-Analyst summarization of the company business strategy.
SWOT Analysis-A detailed analysis of the company strengths, weakness, opportunities and threats.
Company history-Progression of key events associated with the company.
Major products and services-A list of major products, services and brands of the company.
Key competitors-A list of key competitors to the company.
Key employees-A list of the key executives of the company.
Executive biographies-A brief summary of the executives' employment history.
Key operational heads-A list of personnel heading key departments/functions.
Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Evonik Industries AG (Evonik) is a specialty chemical company. Its activities focus on high-growth megatrends, especially health, nutrition, resource efficiency and globalization. The company offers specialty chemicals, healthcare products, polymer materials and intermediates. Its products find application in various markets including adhesives and sealants, automotive, agriculture, coatings, composites, construction, design, electronics and telecommunications, environment and utilities, food, feed, plastics, pharmaceuticals and others. Evonik also offers process technology, technical, logistics and engineering services. It operates production facilities in Germany, Belgium, the US and China and Singapore among others. The company has presence in North America, Asia, Africa, South America, Europe and Australia. Evonik is headquartered in Essen, Germany.
Evonik Industries AG Key Recent Developments
Jul 04,2017: Japanese Manufacturer Partners AMAC For European Expansion
Jun 20,2017: Evonik Signs New Syndicated Credit Facility Totaling EUR1.75 Billion
May 16,2017: Evonik to showcase CYROLITE polymers for medical devices, expanding applications in blood-contacting area
Apr 28,2017: Raven Celebrates Groundbreaking And Announces Appointment Of Kevin C. Clement To Board Of Managers
Jan 20,2017: MIDO 2017: Evonik presents TROGAMID for more freedom of design in optical applications
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1-About the Company 6
Evonik Industries AG-Key Facts 6
Evonik Industries AG-Key Employees 7
Evonik Industries AG-Key Employee Biographies 8
Evonik Industries AG-Major Products and Services 9
Evonik Industries AG-History 12
Evonik Industries AG-Company Statement 18
Evonik Industries AG-Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Joint Venture 22
Section 2-Company Analysis 23
Evonik Industries AG-Business Description 23
Evonik Industries AG-Corporate Strategy 24
Evonik Industries AG-SWOT Analysis 25
SWOT Analysis-Overview 25
Evonik Industries AG-Strengths 25
Evonik Industries AG-Weaknesses 26
Evonik Industries AG-Opportunities 27
Evonik Industries AG-Threats 28
Evonik Industries AG-Key Competitors 29
Section 3-Company Financial Ratios 30
Financial Ratios-Capital Market Ratios 30
Financial Ratios-Annual Ratios 31
Performance Chart 34
Financial Performance 34
Financial Ratios-Interim Ratios 35
Financial Ratios-Ratio Charts 36
Section 4-Company's Lifesciences, Power Financial Deals and Alliances 37
Evonik Industries AG, Petrochemicals, Deals By Year, 2011 to YTD 2017 37
Evonik Industries AG, Petrochemicals, Deals By Type, 2011 to YTD 2017 38
Evonik Industries AG, Recent Deals Summary 39
Section 5-Company's Recent Developments 40
Jun 20, 2017: Evonik Signs New Syndicated Credit Facility Totaling EUR1.75 Billion 40
May 16, 2017: Evonik to showcase CYROLITE polymers for medical devices, expanding applications in blood-contacting area 41
Apr 28, 2017: Raven Celebrates Groundbreaking And Announces Appointment Of Kevin C. Clement To Board Of Managers 42
Jan 20, 2017: MIDO 2017: Evonik presents TROGAMID for more freedom of design in optical applications 43
Nov 16, 2016: Raven On-Purpose Butene-1 Facility Announces Capital Commitments And EPC Contract 44
Nov 04, 2016: Evonik Announces Financial Results For Third Quarter 2016 45
Oct 19, 2016: CYROLITE-Multipolymer Compounds for Medical Devices 47
Oct 04, 2016: Evonik presents liposomal drug delivery systems and celebrates 30th anniversary of RESOMER at CPhl worldwide in Barcelona 48
Sep 13, 2016: Price Increase For Evonik's PMMA Molding Compounds 49
Aug 31, 2016: Evonik Birmingham Laboratories receives renewal of GMP certification 50
Section 6-Appendix 51
Methodology 51
Ratio Definitions 51
About GlobalData 55
Contact Us 55
Disclaimer 55
List of Figure
List of Figures
Evonik Industries AG, Performance Chart (2012-2016) 34
Evonik Industries AG, Ratio Charts 36
Evonik Industries AG, Petrochemicals, Deals By Year, 2011 to YTD 2017 37
Evonik Industries AG, Petrochemicals, Deals by Type, 2011 to YTD 2017 38
List of Table
List of Tables
Evonik Industries AG, Key Facts 6
Evonik Industries AG, Key Employees 7
Evonik Industries AG, Key Employee Biographies 8
Evonik Industries AG, Major Products and Services 9
Evonik Industries AG, History 12
Evonik Industries AG, Subsidiaries 20
Evonik Industries AG, Joint Venture 22
Evonik Industries AG, Key Competitors 29
Evonik Industries AG, Ratios based on current share price 30
Evonik Industries AG, Annual Ratios 31
Evonik Industries AG, Annual Ratios (Cont...1) 32
Evonik Industries AG, Annual Ratios (Cont...2) 33
Evonik Industries AG, Interim Ratios 35
Evonik Industries AG, Petrochemicals, Deals By Year, 2011 to YTD 2017 37
Evonik Industries AG, Petrochemicals, Deals By Type, 2011 to YTD 2017 38
Evonik Industries AG, Recent Deals Summary 39
Currency Codes 51
Capital Market Ratios 51
Equity Ratios 52
Profitability Ratios 52
Cost Ratios 53
Liquidity Ratios 53
Leverage Ratios 54
Efficiency Ratios 54
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.